Skip to main content
. 2006 May 2;94(10):1510–1515. doi: 10.1038/sj.bjc.6603149

Figure 1.

Figure 1

Four-year event-free survival of neuroblastoma infants detected by mass screening based on MYCN amplification. The curve was generated with the Kaplan and Meier product limit method. The 4-year OS rate was 99% for patients without MNA, 89% for patients with amplification from three to nine copies, and 53% for patients with more than 10 copies (P<0.001).